A microRNA signature that correlates with cognition and is a target against cognitive decline
Abstract While some individuals age without pathological memory impairments, others develop age‐associated cognitive diseases. Since changes in cognitive function develop slowly over time in these patients, they are often diagnosed at an advanced stage of molecular pathology, a time point when causa...
Saved in:
Similar Items
-
The economic burden of subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia: excess costs and associated clinical and risk factors
by: Eva Gläser, et al.
Published: (2025-06-01) -
Perivascular space and white matter hyperintensities in Alzheimer’s disease: associations with disease progression and cognitive function
by: Philine Marie Schirge, et al.
Published: (2025-03-01) -
Longitudinal evidence for a mutually reinforcing relationship between white matter hyperintensities and cortical thickness in cognitively unimpaired older adults
by: Jose Bernal, et al.
Published: (2024-10-01) -
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects
by: Lara Blömeke, et al.
Published: (2024-12-01) -
Characterization of a pathogenic gain-of-function mutation in the N-terminal domain of STAT1 which is reported to be associated with eosinophilic esophagitis
by: Kristin Annawald, et al.
Published: (2025-08-01)